Prolacta Bioscience Information

Prolacta Bioscience reduces premature infant complications and hospital costs with 100% human milk-based fortifiers and formulas. Trusted by more than 55% of Level 3&4 U.S. NICUs. Prolacta has helped change the standard of care for more than 125,000 critically ill and premature infants, since introducing the world’s first and only 100% human milk-based fortifier. Our nutritional products have been evaluated in 30+ peer-reviewed clinical studies, demonstrating shorter NICU stays and better outcomes for premature infants born weighing <1250 g, compared to cow milk-based products. Extending the clinically proven benefits of human milk, Prolacta has developed Surgifort®, the first and only FDA-approved human milk-based fortifier designed for term infants recovering from corrective surgery for gastroschisis. Learn how Prolacta’s Exclusive Human Milk Diet can improve outcomes and reduce total hospital costs. Visit Prolacta.com